Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy guatemalan males

Annals of Nutrition and Metabolism

Volumn 60, Issue 2, 2012, Pages 98-107

  Schmann, Klaus ^a   Kroll, Sylvia ^a   Romero Abal, Maria Eugenia ^b   Georgiou, Niki A ^c   Marx, Jo J M ^c   Weiss, Gnter ^d   Solomons, Noel W ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Center for Studies of Sensory Impairment Aging and Metabolism Guatemala   (Guatemala)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Ferritin; Guatemala; Iron absorption; Iron status; Non transferrin bound iron; Serum iron

Indexed keywords

FERRITIN; FERROUS SULFATE; HEMOGLOBIN; IRON; TRANSFERRIN;

ABSORPTION; ADULT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FERRITIN BLOOD LEVEL; GUATEMALA; HUMAN; HUMAN EXPERIMENT; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SUPPLEMENTATION;

ADULT; COHORT STUDIES; DIETARY SUPPLEMENTS; FERRITINS; FERROUS COMPOUNDS; GUATEMALA; HEMATINICS; HEMOGLOBINS; HUMANS; INTESTINAL ABSORPTION; IRON; IRON, DIETARY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TRANSFERRIN; YOUNG ADULT;

EID: 84857765816     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000336177     Document Type: Article

References (48)

1. Hershko C, Graham G, Bates GW, Rachmilewitz EA: Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978; 40: 255-269.
2. Chrichton R: Transferrin iron binding and release; in Crichton R (ed): Inorganic Biochemistry of Iron Metabolism. Chichester, Willey, 2001, pp 111-114.
3. Jacobs WMG, Hendriks JCM, van Tits BLJH, et al: Results of an international round robin for the quantification of serum non-transferrin-bond iron: need for defining standardization and a clinically relevant isoform. Anal Biochem 2005; 341: 241-250. (Pubitemid 40724808)
4. Simpson RJ, Cooper CE, Raja KB, et al: Nontransferrin-bound iron species in the serum of hypotransferrinaemic mice. Biochim Biophys Acta 1992; 1156: 19-26. (Pubitemid 23004900)
5. Breuer W, Hershko C, Cabantchik ZI: The importance of non-transferrin-bound iron in disorders of iron metabolism. Transfus Sci 2000; 23: 185-192.
6. Esposito BP, Breuer W, Sirinkarpracha P, et al: Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 2003; 102: 2670-2677. (Pubitemid 37193611)
7. LeLan C, Loreal O, Cohen T, et al: Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood 2005; 105: 4527-4531. (Pubitemid 40720804)
8. deValk B, Addicks MA, Gosriwatana I, et al: Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000; 30: 248-251. (Pubitemid 30153666)
9. Hutchison C, Al-Ashgar W, Liu DY, et al: Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron. Eur J Clin Invest 2004; 34: 782-784. (Pubitemid 39524304)
10. Dresow B, Petersen D, Fischer R, Nielsen P: Non-transferrin-bound iron in plasma followed administration of oral iron drugs. Biometals 2008; 21: 273-276. (Pubitemid 351579742)
11. Kiechel S, Willeit J, Egger G, Poewe W, Oberhollenzer F: Body iron stores and the risk of carotide atherosclerosis: prospective results from the Bruneck study. Circulation 1997; 96: 3300-3307. (Pubitemid 27513398)
12. Darlea Usmar V, Halliwell B: Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996; 13: 649-662. (Pubitemid 26156215)
13. Patruta SI, Edlinger R, Sunder-Plassmann G, Hörl WH: Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 1998; 9: 655-663. (Pubitemid 28186054)
14. Barton Pai A, Pai MP, Depczynski J, Mc-Quade CR, Mercier RC: Non-transferrinbound iron is associated with enhanced Staphylococcus aureus growth in haemodialysed patients receiving intravenous iron sucrose. Am J Nephrol 2006; 26: 304-309. (Pubitemid 44114402)
15. Canziani ME, Yumiya ST, Rangel EB, et al: Risk of bacterial infection in patients un-der intravenous iron therapy: doses versus length of treatment. Artif Organs 2001; 25: 866-869. (Pubitemid 34036496)
16. Gray C, McCormick C, Turner G, Craig A: ICAM-1 can play a major role in mediating P. falciparum adhesion to endothelium under flow. Mol Biochem Parasitol 2003; 128: 187-193. (Pubitemid 36549248)
17. Kartikasari AER, Georgiou NA, Visserer FLJ, et al: Endothelial activation and induction of monocyte adhesion by non-transferrin-bound iron present in human sera. FASEB J 2005; 20: 353-355. (Pubitemid 46671169)
18. Matinaho S, Karkumäki P, Parkkinen J: Bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrinbound iron. Transfusion 2005; 45: 1768-1773. (Pubitemid 43923904)
19. McLean E, Egli I, Cogswell M, de Benoist B, Wijdla D: Worldwide prevalence of anemia in preschool aged children, pregnant women and non-pregnant women of reproductive age; in Kraemer K, Zimmerman T (eds): Nutritional Anemia. Basel, Sight & Life Press, 2007, pp 1-12.
20. Stolzfus RJ, Dreyfuss ML: Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia. Washington, ILSI Press, 1998.
21. Sazawal S, Black RE, Ramsan M, et al: Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006; 367: 133-143. (Pubitemid 43077129)
22. English M, Snow RW: Iron and folic acid supplementation and malaria risk. Lancet 2006; 367: 90-91. (Pubitemid 43077110)
23. Bothwell TH, Charlton RW, Cook JD, Finch CA: Plasma iron; in Bothwell TH, Charlton RW, Cook JD, Finch CA (eds): Iron Metabolism in Men. Oxford, Blackwell Scientific Publications, 1979, pp 284-310.
24. Breuer W, Cabantchik ZI: A fluorescencebased one-step assay for serum non-transferrin-bound iron. Anal Biochem 2001; 299: 194-202. (Pubitemid 34053410)
25. Ekenved G, Norrby A, Sölvell L: Serum iron increase as a measure of iron absorption-studies on the correlation with total absorption. Scand J Haematol Suppl 1976; 28: 31-49.
26. Ekenved G: Absorption from different types of iron tablets-correlation between serum iron increase and total absorption of iron. Scand J Haematol Suppl 1976; 28: 51-63.
27. Schächner E, Ronen M, Pinklaus J, Djaldetti M: Iron absorption in patients with polycythemia vera: a comparative study using the whole-body counter and the ferrous sulfate absorption text. Eur J Nucl Med 1978; 3: 125-127. (Pubitemid 8300382)
28. Heinrich HC, Fischer R: Correlation of postabsorptive serum iron increase and erythrocyte-59 Fe-incorporation with the whole body retention of absorbed 59 Fe. Klin Wochenschr 1982; 60: 1493-1496. (Pubitemid 13196486)
29. Hoppe M, Hulthen L, Hallberg L: The validation of using serum iron increase to measure iron absorption in subjects. Br J Nutr 2004; 92: 485-488. (Pubitemid 40277069)
30. Kaltwasser JP, Schwarz-van de Sand W: Orale Eisentherapie: Bioverfügbarkeit und therapeutische Wirksamkeit von Ferro-Eisen als Brausetabletten bei posthämorrhagischer Eisenmangelanämie. Dtsch Med Wochenschr 1989; 114: 1188-1195. (Pubitemid 19201483)
31. Dirren H, Logman MH, Barclay DV, Freire WB: Altitude correction for hemoglobin. Eur J Clin Nutr 1994; 48: 625-632. (Pubitemid 24275920)
32. Bothwell TH, Charlton RW, Cook JD, Finch CA: Iron absorption; in Bothwell TH, Charlton RW, Cook JD, Finch CA (eds): Iron Metabolism in Man. Oxford, Blackwell, 1979, pp 256-283.
33. Beard JL, Dawson H, Pinero DJ: Iron metabolism: a comprehensive review. Nutr Rev 1996; 54: 295-317. (Pubitemid 27129673)
34. Beard J: Iron; in Bowman BA, Russell RM (eds): Present Knowledge in Nutrition, ed 9. Washington, ILSI Press, 2007, pp 445-457.
35. de Benoist B, Fontaine O: Summary of the Conclusions of the WHO Consultation on Prevention and Control of Iron Deficiency in Infants and Young Children in Malaria Endemic Areas. Lyon, World Health Organization, 2007.
36. Schümann K, Ettle T, Szegner B, Elsenhans B, Solomons NW: On risks and benefits of iron supplementation recommendations for iron intake revisited. J Trace Elem Med Biol 2007; 21: 147-168. (Pubitemid 47241218)
37. Slotkin S, Tondeur M: Successful approaches: sprinkles; in Kraemer K, Zimmerman T (eds): Nutritional Anemia. Basel, Sight & Life Press, 2007, pp 269-284.
38. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 1998; 47: 1-29.
39. Pena-Rosas JP, Nesheim MC, Garcia-Casal MN, et al: Intermittent iron supplementation regimens are able to maintain safe maternal hemoglobin concentrations during pregnancy in Venezuela. J Nutr 2004; 134: 1099-1104. (Pubitemid 38647175)
40. Solomons NW, Schümann K: Safety of interventions; in Kraemer K, Zimmerman M (eds): Nutritional Anemia. Basel, Sight & Life Press, 2007, pp 285-314.
41. Hider RC: Nature of non-transferrin-bound iron. Eur J Clin Nutr 2002; 32(suppl I):50-54.
42. Sahlstedt L, Ebeling F, von Bansdarf L, Parkinen J, Ruutu T: Non-transferrin-bound iron during allogenic stem cell transplantation. Br J Haematol 2001; 113: 836-838. (Pubitemid 32524411)
43. Ettle T, Elsenhans B, Windisch W, Srai SKS, Schümann K: Mobilisation of recently absorbed 59 Fe in ex vivo perfused rat duodena and the influence of iron status and subsequently absorbed chelators. J Trace Elem Med Biol 2006; 19: 231-241. (Pubitemid 43144584)
44. Martell AE, Smith RM: Critical Stability Constants. New York, Plenum Press, 1974.
45. Bates GW, Billups C, Saltman P: The kinetics and mechanism of Fe(III) exchange between chelates and transferrin. I. The complexes of citrate and nitrilotriacetic acid. J Biol Chem 1967; 242: 2810-2815.
46. Bates GW, Billups C, Saltman P: The kinetics and mechanism of Fe(III) exchange between chelates and transferrin. II. The presentation and removal with ethylenediaminetetracetate. J Biol Chem 1967; 242: 2816-2821.
47. Muta K, Nishimura J, Ideguchi H, Umemura T, Ibayashi H: Erythroblast transferrin receptors and transferrin kinetics in iron deficiency and various anemias. Am J Hematol 1987; 25: 155-163. (Pubitemid 17108012)
48. Schümann K, Szegner B, Kohler B, Pfaffl M, Ettle T: A method to assess 59 Fe in residual tissue blood content in mice and its use to correct 59 Fe-distribution kinetics accordingly. Toxicology 2007; 241: 19-32. (Pubitemid 47603207)